&w=3840&q=100)
Thinking of investing in Anthem Biosciences IPO? Know key risks, strengths
The public issue is entirely an Offer for Sale (OFS), with promoters and existing shareholders divesting up to 59.6 million equity shares, aggregating to approximately ₹3,395 crore.
From the promoter group, Ganesh Sambasivam and K Ravindra Chandrappa are among those participating in the OFS. Viridity Tone LLP, Portsmouth Technologies LLC, and Malay J. Barua are among the shareholders divesting their stakes through the Anthem Biosciences IPO.
Anthem Biosciences has set the price band for the IPO at ₹540 to ₹570 per share. The minimum application size has been set at 26 shares per lot. The issue will open for subscription on July 14 and remain available until July 16. The company's shares are tentatively scheduled to make their D-Street debut on July 21, 2025.
It is worth noting that Anthem Biosciences will not receive any proceeds from the IPO. All the funds raised will go directly to the selling shareholders, after accounting for offer-related expenses and applicable taxes, which will be borne by the respective sellers.
As investors await the opening of Anthem Biosciences IPO, here are the key strengths and risks outlined in its Red Herring Prospectus (RHP) that every investor should be aware of:
Key strengths of Anthem Biosciences
Strong global customer base with long-term relationships: As of March 31, 2025, Anthem Biosciences had more than 550 customers across both its CRDMO and specialty ingredients businesses, spread over more than 44 countries, including the United States, European countries, and Japan. Many of these customers have long-standing relationships with the company. According to the F&S Report, Anthem Biosciences has the highest number of customers among its assessed Indian peers as of March 2025.
Market-leading fermentation capacity: The company has the largest fermentation capacity among Indian CRDMO companies, with a 142 kL capacity as of March 31, 2025. Following the completion of its expansion activities by the first half of Fiscal 2026, Anthem Biosciences' fermentation capacity is expected to reach 182 kL—more than six times the fermentation capacity of the second-largest assessed player in the industry, according to the F&S Report.
Diversified specialty ingredients portfolio: Anthem Biosciences also maintains a wide specialty ingredients portfolio and is well-positioned to capitalise on the large market opportunity for niche specialty ingredients such as GLP-1, fermentation-based products, probiotics, enzymes, nutritional actives, vitamin analogues, and biosimilars.
Focused business model for emerging pharma and biotech players: According to the F&S Report, while large multinational pharmaceutical companies currently dominate the global pharmaceuticals market, there is a growing prominence of small pharmaceutical and biotech companies, reflecting a broader shift in the pharmaceutical industry towards novel therapies and innovation-driven growth. Anthem Biosciences has a differentiated business model catering to the needs of small pharmaceutical and emerging biotech companies, from discovery to commercial manufacturing.
Comprehensive end-to-end service capabilities: Anthem Biosciences offers comprehensive one-stop service capabilities across the drug life cycle (drug discovery, development, and manufacturing) for both small molecules and biologics and is the fastest-growing Indian CRDMO.
Key risks of Anthem Biosciences
High dependence on CRDMO services: Anthem Biosciences' business depends on the demand for its contract research, development and manufacturing organisation (CRDMO) services, which contributed to 81.65 per cent of its revenue from operations in Fiscal 2025. Any adverse impact on its CRDMO customers' business or the industries in which they operate may have a material adverse effect on the company's business.
Dependence on DavosPharma for US market presence: Anthem Biosciences is dependent on its arrangements with DavosPharma, the affiliate of one of its shareholders and also a selling shareholder, for its business and marketing activities in the United States.
Reliance on the success of specific molecules: The company's financial performance is dependent on the success of the molecules it manufactures, and its revenue from operations decreased in Fiscal 2023 compared to Fiscal 2022, partly attributable to the failure of a Phase III molecule and the withdrawal of a commercialised molecule. Accordingly, any unfavorable developments affecting these molecules' success rates, including failures to obtain the required regulatory approvals or withdrawal of commercialised molecules, may have an adverse impact on Anthem Biosciences' business, financial condition, results of operations, and prospects.
Risks associated with project failures: Developmental and commercial manufacturing contributed to 70.78 per cent of Anthem Biosciences' revenue from operations and 71.90 per cent of its total number of projects in Fiscal 2025. The company's business may be adversely affected by a failure in early-phase developmental projects or a failure to develop or manufacture commercially viable drugs, including for reasons that are not within Anthem Biosciences' control.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
34 minutes ago
- Business Standard
125 immigrant billionaires now hold $1.3 trillion of America's wealth
Immigrants aren't just cheap labour — they help make America wealthier. The 2025 Forbes list of foreign-born billionaires living in the US, along with Meta's newly announced Superintelligence Lab run entirely by immigrant researchers, reflects how central immigrants have become to the country's growth — economically and technologically. A record 125 foreign-born American citizens now appear on Forbes' annual list of billionaires residing in the US, up from 92 in 2022. Together, they account for 14 per cent of America's nearly 900 billionaires and hold $1.3 trillion in combined wealth — around 18 per cent of the country's total billionaire fortune. Among the top 10 richest Americans, three are immigrants. The world's wealthiest person, Elon Musk, was born in South Africa and moved to the US via Canada as a student. He is now worth $393.1 billion. Google cofounder Sergey Brin, who came to the US from Russia as a child, follows with a net worth of $139.7 billion. Nvidia's Jensen Huang, born in Taiwan and sent to the US as a child during political unrest in Thailand, is worth $137.9 billion. These 125 billionaire immigrants hail from 43 countries, but most were born in just a handful of places. • Indian-origin immigrants leads with 12 billionaires, up from 7 in 2022 • Taiwan and Israel follow closely with 11 each • Canada (9), China (8), and Germany and Iran (6 each) also feature prominently Among the new entrants are AMD CEO Lisa Su, cousin of Nvidia's Huang, and Iranian-born biotech leader Maky Zanganeh, now co-CEO of Summit Therapeutics. 'Being an immigrant is about seeking the best opportunities and learning to adapt to new environments,' Forbes quoted Zanganeh, whose firm's lung cancer drug candidate helped push her into the billionaire bracket. Indians added five new immigrant billionaires this year — more than any other country. Sundar Pichai, Satya Nadella, and Nikesh Arora are now part of this cohort, joining other US-based billionaires like Jay Chaudhry, Vinod Khosla, and Romesh Wadhwani. Most are self-made, and many came for education While over a quarter of US billionaires inherited their wealth, 93 per cent of immigrant billionaires built it themselves. Nearly two-thirds made their fortune in tech (53 people) or finance (28 people). Many came to the US for higher education and stayed on. According to Forbes, Musk arrived to study at the University of Pennsylvania. Jay Chaudhry, now worth $17.9 billion, flew from India to the University of Cincinnati in 1980 having never been on a plane. Shahid Khan, owner of the Jacksonville Jaguars, arrived at 16 to study in Illinois and washed dishes for $1.20 an hour his first day. Immigrants leading Meta's AI lab Beyond billionaires, immigrants are also behind some of the most cutting-edge innovation in the US today. Meta's newly launched Superintelligence Lab, tasked with building next-generation AI systems, is staffed entirely by immigrant researchers. The 11-member team includes talent from India, China, the UK, South Africa, and Australia — all with advanced US university degrees and work histories at top AI firms like OpenAI, Google and DeepMind. 'Meta's Superintelligence Lab, led entirely by immigrant researchers, is the practical reality we needed to see,' Praneet Singh, AVP of University Partnership at upGrad's study abroad division told Business Standard. 'AI innovation is truly going borderless and India continues to serve as a strong hub of ready talent.' He added, 'It's quite paradoxical, though — while our talent is ready, mobility remains constrained. Despite policy shifts like STEM OPT extensions and improved green card processing, visa constraints and bureaucratic uncertainties continue to slow down global movement.' This rise in immigrant wealth and innovation comes against the backdrop of tighter immigration scrutiny under the Trump administration, with longer visa processing times and expanded enforcement.
Fashion Value Chain
34 minutes ago
- Fashion Value Chain
Crompton Introduces Ameo Fresh Nutri Blender, Reinforcing Its Promise of ‘Healthy Choices Made Easy'
In today's fast-paced world, maintaining healthy eating habits can be a challenge. To address this, Crompton Greaves Consumer Electricals Ltd., a trusted name in the Indian consumer durables market, has launched the Ameo Fresh Nutri Blender – a next-generation, compact appliance designed for busy, health-conscious individuals. Emphasizing the slogan 'Healthy Choices Made Easy', the Ameo Fresh Nutri Blender is thoughtfully engineered to enhance daily nutrition, seamlessly fitting into modern kitchens. As a trusted brand with a wide consumer base in the Indian market, Crompton is committed to meaningful innovation that aligns with the growing focus on healthy living. Crompton Ameo Fresh Nutri Blender In a world where mornings are rushed and nutrition often takes a backseat, preparing fresh, wholesome meals can feel like a challenge. Working professionals and young families are steadily moving away from packaged foods, gravitating instead towards solutions that enable quick, hygienic, and reliable food preparation. The Ameo Fresh Nutri Blender is a testament to Crompton's commitment to empowering consumers with tools that facilitate healthier living in an increasingly busy world. With a powerful 400 watts of blending performance, this sleek blender effortlessly combines convenience and efficiency, making it an essential tool for quick and nutritious meal preparation. By simplifying the preparation of healthy meals, Crompton not only supports individual health and wellness goals, but also encourages a broader lifestyle change toward nutrition and wellness. The product boasts a range of user-centric features designed for practical, everyday benefits: Lump-free quick blends with Maxi blend technology : Specially crafted stainless-steel blades and jar design to create a vortex motion ideal for creamy smoothies, shakes, dips, baby food, and more Safety and Convenience : With a Power Button and unique Intelligent Locking Mechanism, ensuring safe and hassle-free use Hygienic food preparation : All jars are made from BPA-free and SS 304 stainless blades, to create delicious and healthy recipes without any concerns Leakage-Free Operation : The leak-proof base offers a clean, spill-free blending experience Easy to use and carry : Add-on sipper cap and storage lids allow users to blend and carry drinks in the same jar, ideal for busy mornings or on-the-go refreshment Next gen Compact Design: Space- saving compact design for compact kitchens without compromising on performance Speaking about the new launch, Ketan Chaudhari, PL Head – Small Domestic Appliances, Crompton Greaves Consumer Electricals Ltd. said, 'Today's consumer isn't just looking for appliances – they're looking for enablers of better living. With the Ameo Fresh Nutri Blender, our goal was to create something that fits seamlessly into the everyday – not just in function, but in design and aesthetics. Whether it's the early rush before work or trying to make healthier choices for your family, this product is designed to support real-life routines. It's another step in our journey to make Crompton synonymous with smart, healthy living for Indian homes.' The Crompton Ameo Fresh Nutri Blender is now available on e-commerce platforms in India at an MRP of INR 5,299/-. With this launch, Crompton further strengthens its presence in the food preparation category, offering a compact yet powerful solution for consumers looking to adopt healthier habits – one blend at a time. About Crompton With a brand legacy of over 85 years, Crompton Greaves Consumer Electricals Ltd. is India's market leader in the category of fans and residential pumps. Over the years, the organization has continuously strived to produce a range of innovative products that cater to the modern consumer including superior quality and high-performance fans, pumps, lighting solutions and a range of other categories like water heaters; air coolers; small kitchen appliances like mixer grinders, air fryers, OTG, electric kettles etc.; other home appliances like irons & built-in kitchen appliances. The company has further invested in brand and innovation to not only better understand and meet consumer needs, but to also help drive energy efficiency. The consumer business also has a well-established and organized distribution network driven by a strong dealer base across the country offering a wide service network and robust after sales service to its customers. The companys consistent dedication to developing energy-efficient products has led to significant recognition. It has been honored with three prestigious National Energy Consumer Awards (NECA) by BEE, Ministry of Power. The recent award was presented by the Hon'ble President of India, Smt. Droupadi Murmu for the companys storage water heater in 2023. In 2019, the brand won in two categories: Ceiling Fans and LED Bulbs. Additionally, it was recognized as one of Indias Best Managed Companies 2022 by Deloitte Private and listed among 'India's Top 500 companies 2022' by Dun & Bradstreet India. The company has also been featured in Brand Top 75 most valuable Indian brands list for 2020 released by WPP and Kantar. Furthermore, Crompton was also recognized as the Brand of the Decade 2021 by Herald Global and BARC Asia in the Consumer Electrical category.
Time of India
44 minutes ago
- Time of India
Indian enterprises in Singapore set to ride on biz adaptation grant to counter US tariff impact
The Singapore Indian Chamber of Commerce and Industry has welcomed the government's timely introduction of the Business Adaptation Grant to help local entrepreneurs navigate and adjust to the evolving cross-border tax landscape, especially impacted by the US trade tariffs . "This grant is available to all local businesses, especially Small and Medium Enterprises (SMEs)," the business chamber said. The Singapore government will launch a Business Adaptation Grant in October to help companies in the city-state adapt to the new US tariff environment, the Singapore Economic Resilience Taskforce (SERT) announced on Thursday. The grant will be capped at SGD 1,00,000 (USD 78,000) per company, said Minister for Manpower Tan See Leng. While Singapore has not received a letter, neighbouring countries such as Malaysia and Indonesia will face tariffs of 25 per cent and 32 per cent, respectively. Live Events "This initiative reflects a proactive and strategic approach to supporting enterprises, particularly SMEs, as they face increasing complexities in international trade ," the Singapore Indian Chamber of Commerce and Industry (SICCI) said. With global tariff structures becoming increasingly dynamic, businesses must be equipped with the necessary tools, knowledge, and financial support to realign their operations and maintain competitiveness, said the Chambers. This grant will offer critical support to companies in reviewing supply chains, recalibrating pricing strategies, exploring alternative markets, and investing in trade advisory capabilities, SICCI said, stressing that it is "fully prepared to provide unwavering support to our members and the wider business community in accessing and leveraging this grant". "We will work closely with government agencies, particularly Enterprise Singapore, to ensure that businesses, especially those from the Indian business community, can effectively benefit from this initiative and develop sustainable trade strategies in response to the shifting global trade Environment," Neil Parekh, Chairman of the Singapore Indian Chamber of Commerce and Industry, said. Tan pointed out that small and medium enterprises will likely be able to receive a higher percentage of co-funding from the government than multinational firms. Small and medium enterprises employ around two-thirds of Singapore's workers, he added. Singapore plays an international hub role in international businesses' global dealings, the US being one of the main lucrative markets, according to international business analysis. The grant will cover two categories of businesses, and eligible companies will get support for a "time-bound period" of two years, according to reports.
